Showing results (1851-1860 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 3, 2005
Prevention of de novo prostate cancer by immunization with tumor-derived vaccinesMark A Suckow, William R Wolter, Morris Pollard
Cancer Immunology, Immunotherapy : CII|January 17, 2022
Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitorsYuhei Harutani, Yuichi Ozawa, Eriko Murakami, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2021
Alterations of circulating lymphocyte subsets in patients with colorectal carcinomaJohanna Waidhauser, Pia Nerlinger, Tim Tobias Arndt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chainS A Eccles, D P McIntosh, H P Purvies, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2021
Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathwayTao Lu, Ming Li, Mengnan Zhao, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2S R Zhang, R R Salup, P E Urias, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytesH F Dullens, S Schakenraad, A Oostdijk, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2022
PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma modelXin Hu, Yifang Shui, Hiroshi Hirano, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2022
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2022
Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomyRiki Okita, Yuka Mimura-Kimura, Nobutaka Kawamoto, et al.
Pageof 652